Dr. Daniel Zapata

Dr. Daniel Zapata
Dr. Zapata attended medical school at Fundación Universitaria de Ciencias de la Salud in Bogotá, Colombia. After working in rural medicine and emergency medicine in Colombia, Dr. Zapata became a research fellow at Duke University Medical Center in Durham, North Carolina. He then completed a general surgery internship and urology residency at University of Tennessee Health Science Center in Memphis. Dr. Daniel Zapata has a primary focus in minimally invasive procedures for benign prostatic hyperplasia, prostate cancer and stone disease as well as surgical treatment for overactive bladder and incontinence for men and women. He is excited to now offer Aquablation Therapy to patients across North Arkansas.

Languages Spoken:

English, Spanish

Medical School:

Fundación Universitaria de Ciencias de la Salud in Bogota, Colombia


Urology, University of Tennessee Health Science Center in Memphis, Tennessee

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only